BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamel SI, de Jong MC, Schulick RD, Diaz-Montes TP, Wolfgang CL, Hirose K, Edil BH, Choti MA, Anders RA, Pawlik TM. The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg. 2011;35:1345-1354. [PMID: 21452068 DOI: 10.1007/s00268-011-1074-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Nasser S, Lathouras K, Nixon K, Campbell J, Stocks G, Jiao L, Fotopoulou C. Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer. Gynecologic Oncology 2018;151:466-70. [DOI: 10.1016/j.ygyno.2018.09.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Schwarz C, Kaczirek K, Bodingbauer M. Liver resection for non-colorectal metastases. Eur Surg 2018;50:113-6. [PMID: 29875799 DOI: 10.1007/s10353-018-0528-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bacalbasa N, Dima S, Brasoveanu V, David L, Balescu I, Purnichescu-Purtan R, Popescu I. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit. World J Surg Oncol. 2015;13:235. [PMID: 26243426 DOI: 10.1186/s12957-015-0652-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
4 Mpabanzi L, van Mierlo KM, Malagó M, Dejong CH, Lytras D, Olde Damink SW. Surrogate endpoints in liver surgery related trials: a systematic review of the literature. HPB (Oxford) 2013;15:327-36. [PMID: 23323939 DOI: 10.1111/j.1477-2574.2012.00590.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
5 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
6 Clair KH, Wolford J, Zell JA, Bristow RE. Surgical Management of Gynecologic Cancers. Surg Oncol Clin N Am 2021;30:69-88. [PMID: 33220810 DOI: 10.1016/j.soc.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu X, Wang Q, Lu Y, Zhang J, Yin H, Yi Y. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer. Sci Rep 2021;11:6069. [PMID: 33727662 DOI: 10.1038/s41598-021-85688-3] [Reference Citation Analysis]
8 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wang M, Zhou J, Zhang L, Zhao Y, Zhang N, Wang L, Zhu W, He X, Zhu H, Xu W, Pan Q, Mao A, Li Q. Surgical treatment of ovarian cancer liver metastasis.Hepatobiliary Surg Nutr. 2019;8:129-137. [PMID: 31098360 DOI: 10.21037/hbsn.2018.12.06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Niu GC, Shen CM, Cui W, Li Q. Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer. Cancer Biol Med. 2012;9:182-187. [PMID: 23691476 DOI: 10.7497/j.issn.2095-3941.2012.03.005] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
11 Hacker NF, Rao A. Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review. Gynecol Oncol Res Pract 2016;3:7. [PMID: 27330821 DOI: 10.1186/s40661-016-0028-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
12 Gallotta V, Conte C, D’indinosante M, Capoluongo E, Minucci A, De Rose AM, Ardito F, Giuliante F, Di Giorgio A, Zannoni GF, Fagotti A, Margreiter C, Scambia G, Ferrandina G. Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. European Journal of Surgical Oncology 2019;45:2096-102. [DOI: 10.1016/j.ejso.2019.06.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
13 Gandy RC, Bergamin PA, Haghighi KS. Hepatic resection of non-colorectal non-endocrine liver metastases. ANZ J Surg 2017;87:810-4. [PMID: 27037839 DOI: 10.1111/ans.13470] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Richards AM, McGauran MJ. Voluntary assisted dying in gynaecological cancers: A discussion of the history, ethical principles and international perspectives. Aust N Z J Obstet Gynaecol 2022. [PMID: 34994397 DOI: 10.1111/ajo.13475] [Reference Citation Analysis]
15 Adamopoulou K, Gkamprana AM, Patsouras K, Halkia E. Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach. World J Hepatol 2021; 13(9): 1122-1131 [PMID: 34630879 DOI: 10.4254/wjh.v13.i9.1122] [Reference Citation Analysis]